Congenital amegakaryocytic thrombocytopenia (CAMT) is characterised by neonatal thrombocytopenia, with reduced or absent bone marrow megakaryocytes, leading eventually to pancytopenia. The mean age for progression to bone marrow failure is four years, with the earliest reported being six months. We describe a CAMT patient with compound heterozygous mutations of the causative MPL gene (one being a previously unreported splice site mutation in intron 11) who developed pancytopenia within the first month of life. This report emphasises the importance of considering CAMT in the differential diagnosis of congenital aplastic anaemia or idiopathic aplastic anaemia in babies. Pediatr Blood Cancer 2013;60:E94–E96. © 2013 Wiley Periodicals, Inc.

REFERENCES

1 OMIM, Entry —# 604498—Amegakaryocytic Thrombocytopenia, Congenital; CAMT. Available at: http://omim.org/entry/604498.
Google Scholar
2 Dokal I, Vulliamy T. Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev 2008; 22: 141–153.
10.1016/j.blre.2007.11.003
CAS PubMed Web of Science® Google Scholar
3 Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: Clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 2011; 6: 673–681.
10.1055/s-0031-1291377
CAS Web of Science® Google Scholar
4 Ihara K, Ishii E, Eguchi M, et al. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci 1999; 96: 3132–3136.
10.1073/pnas.96.6.3132
CAS PubMed Web of Science® Google Scholar
5 Ballmaier M, Germeshausen M. Advances in the understanding of congenital amegakaryocytic thrombocytopenia. Br J Haematol 2009; 146: 3–16.
10.1111/j.1365-2141.2009.07706.x
CAS PubMed Web of Science® Google Scholar
6 Kobayashi M, Laver J, Kato T, et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 1996; 88: 429–436.
CAS PubMed Web of Science® Google Scholar
7 Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005; 115: 3339–3347.
10.1172/JCI26674
CAS PubMed Web of Science® Google Scholar
8 Yoshihara H, Arai F, Hosokawa K, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007; 1: 685–697.
10.1016/j.stem.2007.10.020
CAS PubMed Web of Science® Google Scholar
9 King S, Germeshausen M, Strauss G, et al. Congenital amegakaryocytic thrombocytopenia: A retrospective clinical analysis of 20 patients. Br J Haematol 2005; 131: 636–644.
10.1111/j.1365-2141.2005.05819.x
CAS PubMed Web of Science® Google Scholar
10 Vermylen C, Cornu G, DeWitte M, et al. Severe idiopathic congenital aplastic anemia: Role of hematopoietic growth factors. Bone Marrow Transplant 1993; 12: 413–415.
CAS PubMed Web of Science® Google Scholar
11 Aladjidi N, Casanova J, Canioni D, et al. Severe aplastic anemia of neonatal onset: A single-center retrospective study of six children. J Pediatr 1998; 132: 600–605.
10.1016/S0022-3476(98)70346-4
CAS PubMed Web of Science® Google Scholar
12 Kuijpers TW, Nannenberg E, Alders M, et al. Congenital aplastic anemia caused by mutations in the SBDS gene: A rare presentation of Shwachman–Diamond syndrome. Pediatrics 2004; 114: e387–e391.
10.1542/peds.2003-0651-F
PubMed Web of Science® Google Scholar

Citing Literature

Volume60, Issue9

September 2013

Pages E94-E96

Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life

Abstract

REFERENCES

Citing Literature

References

Related

Information